Safety and immunogenecity of NIBRG-14 H5N1 01-2005 mock-up vaccine for potencial pandemic vaccine producers in Hungary.
Phase of Trial: Phase IV
Latest Information Update: 18 May 2011
At a glance
- Drugs Influenza A virus vaccine-H5N1 (Primary)
- Indications Influenza virus infections
- Focus Pharmacodynamics
- 18 May 2011 New trial record